Stock listing
Suzhou Ribo Life Science Co. Ltd. Class H
Selected listing: 6938 · HKEX · HKD · HK
Suzhou Ribo Life Science Co. Ltd. Class H (HKEX:6938), Health Technology. Latest release May 12, 2026: Ribo Announces Strategic Collaboration with Insilico…
- Ticker
- HKEX:6938
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Generic
- Exchange
- HKEX
- Currency
- HKD
About Suzhou Ribo Life Science Co. Ltd. Class H
Suzhou Ribo Life Science Co. Ltd. Class H, trading under the ticker 6938, is a publicly listed company on the Hong Kong Stock Exchange. Suzhou Ribo specializes in life sciences, focusing on innovative solutions in the biotechnology sector.
Latest news from Suzhou Ribo Life Science Co. Ltd. Class H
Ribo Announces Strategic Collaboration with Insilico Medicine to Accelerate siRNA Drug Development Driven by AI
May 12, 2026
Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)
May 6, 2026
Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH
February 11, 2026
Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange
January 9, 2026
Research Suzhou Ribo Life Science Co. Ltd. Class H
Suzhou Ribo Life Science Co. Ltd. Class H company profile
View the public company page for Suzhou Ribo Life Science Co. Ltd. Class H on 6ix.
Suzhou Ribo Life Science Co. Ltd. Class H news
Read company news and market updates connected to Suzhou Ribo Life Science Co. Ltd. Class H.
Suzhou Ribo Life Science Co. Ltd. Class H investor events
Find investor webinars, events, and replay context for Suzhou Ribo Life Science Co. Ltd. Class H.